Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer

• मुख्य लेखकों: Shaimaa Hamza (लेखक), Ekaterina E. Garanina (लेखक), Layaly Shkair (लेखक), Mohammad Alsaadi (लेखक), Svetlana F. Khaiboullina (लेखक), Gulcin Tezcan (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2024-02-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

The NLR family pyrin domain containing 3 (NLRP3) promotes the growth of colorectal cancer (CRC). However, the therapeutic effect of NLRP3 inhibition on CRC cell progression is controversial. This study comparatively investigated the therapeutic effect of a pharmacological NLRP3 inhibitor, glibenclam...